Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
It plays a crucial role in various biological processes, including wound healing, skin regeneration, and hair growth
The peptide's effects on fat metabolism also involve its insulin-like actions
This product is about more than a pill
Research does show GHK-Cu: Stimulates collagen and glycosaminoglycan production Improves wound healing in laboratory and clinical settings Reduces inflammation and oxidative stress Supports healthier skin structure over time These effects are well documented in scientific literature, especially in wound care and tissue repair contexts
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
